Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Monday, January 30, 2023.
Entrada Therapeutics, Inc. (NASDAQ:TRDA)
Long-Term Downtrend (-90) - TRDA is in a strong downtrend that is likely to continue. While TRDA is showing intraday strength, it remains in the confines of a bearish trend. Traders should use caution and set stops.
Is it time to buy, sell, or avoid TRDA?
MarketClub looks at technical strength and momentum to determine if the timing is right for TRDA.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for TRDA
The long-term trend has been DOWN since Jan 4th, 2023 at 12.15
The intermediate-term trend has been DOWN since Dec 20th, 2022 at 13.60
The short-term trend has been DOWN since Jan 11th, 2023 at 13.61
Smart Scan Analysis for TRDA
Based on our trend formula, TRDA is rated as a -90 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 11.82 | 12.23 | 11.12 | 11.88 | -0.18 |
| Prev. Close | Volume | Bid | Ask | Time |
| 11.67 | 21689 | 2023-01-30 15:58:33 |
| 52wk High | 24.38 | 52wk High Date | 2022-10-31 |
| 52wk Low | 5.12 | 52wk Low Date | 2022-05-09 |
| Average Volume | 53,134 | Shares Outstanding | 31,406 |
| Assets | 274,463,000M | Liabilities | 41,243,000M |
| P/E Ratio | 0.8463 |